Nls Pharmaceutics Ltd (NLSP) has released an update.
NLS Pharmaceutics Ltd. is currently managing financial claims from several service providers. Cambrex Corporation is seeking payment for an overdue balance of approximately $492,723, while Clinilabs has issued credit notes and invoices demanding around $793,112 in unpaid fees. Additionally, the company has negotiated a structured payment plan with CoreRX, Inc. to settle a claim of over $1 million.
For further insights into NLSP stock, check out TipRanks’ Stock Analysis page.
